07 July 2022 Akin Gump Strauss Hauer & Feld LLP To print this article, all you need is to be registered or login on Mondaq.com. Key Points: For the first time, the Supreme Court has invoked explicitly the “major questions doctrine”—which requires Congress to speak clearly when authorizing agency action in certain…
07 July 2022 Ogletree, Deakins, Nash, Smoak & Stewart To print this article, all you need is to be registered or login on Mondaq.com. On June 2, 2022, Minnesota Governor Tim Walz signed House File (HF) 4065 into law, a measure that provides clarity regarding hemp-derived consumables stemming from the Agriculture Improvement Act…
Introduction On May 13 2022, the Ontario Superior Court of Justice found section 12 of the National Security and Intelligence Committee of Parliamentarians Act (the Act) unconstitutional. Section 12 of the Act removes committee members’ ability to raise parliamentary privilege as a defense in the event that they contravened the Act by releasing confidential national…
06 July 2022 The Sovereign Group To print this article, all you need is to be registered or login on Mondaq.com. It’s never too late to improve your quality of life and you can find all the quality you need by relocating to Cyprus. With an idyllic lifestyle, a rich culture, 340 days of sunshine…
The United States Supreme Court recently issued its decision in Dobbs v. Jackson Women’s Health Org.––– US –––, 2022 WL 2276808 (2022), overturning Roe v. wade410 US 113 (1973), and Planned Parenthood of Southeastern Pennsylvania v. Casey, 505 US 833 (1992). In holding that the US Constitution does not protect a right to abortion, the…
Read More “HIPAA Privacy Concerns Post-Dobbs – Privacy Protection” »
On June 29, in response to the US Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, the US Department of Health & Human Services Office for Civil Rights (HHS OCR) issued guidance on when entities covered by the Health Insurance Portability and Accountability Act (HIPAA) are permitted to share protected health information (PHI)…
04 July 2022 BakerHostets To print this article, all you need is to be registered or login on Mondaq.com. To help guide entities through the significant confusion and changes that will be evolving for the next several years, BakerHostenler has assembled the Dobbs Decision Task Force (DDTF), led by attorneys in five major…
To print this article, all you need is to be registered or login on Mondaq.com. As we noted in our last PBM Regulatory Roundup, there has been a wave of state regulation focused on PBM practices in the wake of Rutledge and webhi. However, PBMs are also facing federal reform efforts. The Pharmacy…
Read More “PBMs Continue To Draw Federal Scrutiny: PBM Transparency Act Of 2022 – Healthcare” »
To print this article, all you need is to be registered or login on Mondaq.com. Medical and diagnostic devices are becoming increasingly advanced, and many are beginning to incorporate cutting-edge Artificial Intelligence (AI) systems into their technology. The already complex regulatory framework is set to become even more complicated with the introduction of…
We provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, market access and competition) since our last update in October 2021. Biosimilars approved in Canada Health Canada has approved eight biosimilars since our last update: Celltrion’s YUFLYMA and JAMP’s SIMLANDI, both marketed, biosimilars of AbbVie’s HUMIRA (adalimumab) …
Read More “Update On Biosimilars In Canada – June 2022 – Healthcare” »
